Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated KRAS G12C-Mutated Non–Small-Cell Lung Cancer: 2-Year Analysis of CodeBreaK 100

Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate...

Descripción completa

Detalles Bibliográficos
Autores principales: Dy, Grace K., Govindan, Ramaswamy, Velcheti, Vamsidhar, Falchook, Gerald S., Italiano, Antoine, Wolf, Jürgen, Sacher, Adrian G., Takahashi, Toshiaki, Ramalingam, Suresh S., Dooms, Christophe, Kim, Dong-Wan, Addeo, Alfredo, Desai, Jayesh, Schuler, Martin, Tomasini, Pascale, Hong, David S., Lito, Piro, Tran, Qui, Jones, Simon, Anderson, Abraham, Hindoyan, Antreas, Snyder, Wendy, Skoulidis, Ferdinandos, Li, Bob T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2023
Materias:
CLINICAL TRIAL UPDATES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414711/
https://www.ncbi.nlm.nih.gov/pubmed/37098232
http://dx.doi.org/10.1200/JCO.22.02524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414711/
https://www.ncbi.nlm.nih.gov/pubmed/37098232
http://dx.doi.org/10.1200/JCO.22.02524

Ejemplares similares